Florida Oncology Associates

Jacksonville, Florida 32256

0 studies enrolling now · 12 studies all time

What they study most

Breast Cancer, Breast Neoplasms, Chronic Lymphocytic Leukemia, Colonic Neoplasms, Colorectal Cancer, Colorectal Neoplasms, Head and Neck Cancer, Locally Recurrent or Metastatic Breast Cancer, Lung Cancer, Non Small Cell Lung Carcinoma, Non-Small Cell Lung Cancer, Non-small-cell Lung Carcinoma

Studies at this site

• Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer — Completed
• Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer — Stopped early
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry) — Completed
• Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer — Completed
• A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer — Completed
• Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer — Completed
• Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors — Completed
• A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients — Completed
• A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL) — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed